2017-2021 US Molecular Diagnostics Market: Supplier Shares and Sales Forecasts by Test and Application

February 2017 | 42 pages | ID: U001330FD9FEN
Venture Planning Group

Abstracts

This report provides an overview of the US molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test. Contains 42 pages and 5 tables

Contents

BUSINESS ENVIRONMENT

1. HEALTH CARE EXPENDITURES
2. COST CONSCIOUSNESS
3. REIMBURSEMENT
4. INDUSTRY CONSOLIDATION
5. MANAGED CARE
a. PPO
b. HMO
6. HOSPITALS
7. ADMISSIONS
8. LENGTH OF STAY
9. INDUSTRY DIVERSIFICATION
10. PHYSICIAN DEMOGRAPHICS
11. POPULATION AGING
  a. Chronic Illness
  b. Disease Incidence
  c. Susceptibility to Iatrogenesis
  d. Multiple Illness Cases
12. LABORATORY REGULATIONS
13. FDA REFORM

MARKET STRUCTURE

1. HOSPITALS
2. COMMERCIAL/PRIVATE LABORATORIES
3. BLOOD BANKS

MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ MARKET SHARES

List Of Tables

LIST OF TABLES

Molecular Diagnostics Test Volume Forecasts by Application
Molecular Diagnostic Sales Forecasts by Application
Market Share of Major Supplier of Molecular Diagnostic Tests
Market Shares of Major Supplier of HIV/Hepatitis Blood Screening Assays
Market Share of Major Supplier of West Nile Virus Blood Screening Assays